Skip to content

In the BioHarmony Drug Report Database

Triheptanoin

Dojolvi (triheptanoin) is a small molecule pharmaceutical. Triheptanoin was first approved as Dojolvi on 2020-06-30. Dojolvi's patent is valid until 2025-10-03 (FDA).
Trade Name Dojolvi
Common Name Triheptanoin
Indication
Drug Class Glycerolipids
Triheptanoin
Get full access now